Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome (Q43134642)

14 November 2017

title

Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome (English)

1 reference

14 November 2017

1 reference

1 reference

1 reference

1 reference

14 November 2017

A Aversa

1 reference

14 November 2017

R Bruzziches

series ordinal

1 reference

14 November 2017

D Francomano

series ordinal

1 reference

14 November 2017

G Spera

series ordinal

1 reference

14 November 2017

publication date

10 March 2010

1 reference

Journal of Endocrinological Investigation

14 November 2017

published in

1 reference

14 November 2017

1 reference

14 November 2017

1 reference

14 November 2017

page(s)

776-783

1 reference

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

The dark side of testosterone deficiency: III. Cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Predicting hypogonadism in men based upon age, presence of erectile dysfunction, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Insulin sensitivity during combined androgen blockade for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Aging, androgens, and the metabolic syndrome in a longitudinal study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

The Aging Males' Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Evaluation of prostate volume by transrectal ultrasonography for use in a brachytherapy program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Testosterone in obesity, metabolic syndrome and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

The role of testosterone in the metabolic syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Androgens, insulin resistance and vascular disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Classification of obesity and assessment of obesity-related health risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

The effect of weight loss on reproductive hormones in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350341

In vivo validation of whole body composition estimates from dual-energy X-ray absorptiometry

21 January 2018

1 reference

12 December 2020

Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis

1 reference

12 December 2020

Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males

1 reference

12 December 2020

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Testosterone supplementation in older men: a rational idea whose time has not yet come.

1 reference

12 December 2020

NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction

1 reference

12 December 2020

Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study

1 reference

12 December 2020

Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency

1 reference

12 December 2020

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

1 reference

12 December 2020

The Aging Males' Symptoms (AMS) scale: update and compilation of international versions

1 reference

12 December 2020

The relationship between serum levels of insulin and sex hormone-binding globulin in men: the effect of weight loss

1 reference

12 December 2020

Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03350341

1 reference

Dimensions Publication ID

14 November 2017

1032044750

0 references

Fatcat ID

release_xzqqrgtnkjetzoxkn5yttn5wem

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xzqqrgtnkjetzoxkn5yttn5wem

24 November 2022

mapped directly with Wikidata item

1 reference